Form 4: Invivyd Director Ajay Royan Acquires Stock Options

Director Ajay Royan acquired stock options in Invivyd, Inc. on May 20, 2025.

Summary

• On May 20, 2025, Ajay Royan, a director of Invivyd, Inc., was granted stock options to purchase 8,219 shares of common stock at an exercise price of $0.8092 per share.
• The options vest fully on the earlier of May 20, 2026, or the date of the Issuer's 2026 Annual Meeting of Stockholders, contingent upon continuous service through the vesting date.
• Following the transaction, Royan directly owns 8,219 derivative securities.

Sentiment

Score: 7

Explanation: The document reflects a standard transaction (stock option grant) which is generally viewed positively as it aligns management interests with shareholders. There are no red flags or negative indicators.

Positives

• The granting of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company.

Industry Context

Stock option grants are a common practice in the biotechnology industry to incentivize and retain key personnel.

Comparison to Industry Standards

• Stock option grants are a typical component of executive compensation packages in the biotech industry, often benchmarked against peer companies of similar size and stage of development.
• Companies like Moderna and BioNTech also utilize stock options as part of their compensation strategy.

Stakeholder Impact

• The stock option grant could potentially increase shareholder value if the director's performance leads to company growth.
• Employees may view the grant positively as it indicates confidence in the company's future.

Key Dates

Keywords

Invivyd, Director, Stock Options, Form 4, Beneficial Ownership, Ajay Royan